Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Uncoupling of VEGF with endothelial NO as a potential mechanism for abnormal angiogenesis in the diabetic nephropathy.

Nakagawa T, Sato W, Kosugi T, Johnson RJ.

J Diabetes Res. 2013;2013:184539. doi: 10.1155/2013/184539. Epub 2013 Dec 9. Review.

3.

Uncoupling of VEGF with NO as a mechanism for diabetic nephropathy.

Nakagawa T.

Diabetes Res Clin Pract. 2008 Nov 13;82 Suppl 1:S67-9. doi: 10.1016/j.diabres.2008.09.030. Epub 2008 Oct 15.

PMID:
18926584
4.

Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats.

Hou N, Huang N, Han F, Zhao J, Liu X, Sun X.

Int Urol Nephrol. 2014 Oct;46(10):2045-51. doi: 10.1007/s11255-014-0807-x. Epub 2014 Aug 15.

PMID:
25118612
5.

Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate.

Tian S, Gan Y, Li J, Wang L, Shen J, Liu T, Ye T, Liu H, Liu D, Deng Y, Wang W.

J Nephrol. 2011 Jul-Aug;24(4):499-506. doi: 10.5301/JN.2011.6458.

PMID:
21425119
6.

Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.

Nakagawa T, Sato W, Glushakova O, Heinig M, Clarke T, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Johnson RJ, Croker B.

J Am Soc Nephrol. 2007 Feb;18(2):539-50. Epub 2007 Jan 3.

7.

Vascular endothelial growth factor receptor-2 and low affinity VEGF binding sites on human glomerular endothelial cells: Biological effects and advanced glycosilation end products modulation.

Pala L, Cresci B, Manuelli C, Maggi E, Yamaguchi YF, Cappugi P, Rotella CM, Giannini S.

Microvasc Res. 2005 Nov;70(3):179-88.

PMID:
16271941
8.

Vascular endothelial growth factor and diabetic nephropathy.

Chen S, Ziyadeh FN.

Curr Diab Rep. 2008 Dec;8(6):470-6. Review.

PMID:
18990304
9.

The pivotal role of VEGF on glomerular macrophage infiltration in advanced diabetic nephropathy.

Sato W, Kosugi T, Zhang L, Roncal CA, Heinig M, Campbell-Thompson M, Yuzawa Y, Atkinson MA, Grant MB, Croker BP, Nakagawa T.

Lab Invest. 2008 Sep;88(9):949-61. doi: 10.1038/labinvest.2008.60. Epub 2008 Jul 7.

10.

The effects of adenosine A2B receptor inhibition on VEGF and nitric oxide axis-mediated renal function in diabetic nephropathy.

Patel L, Thaker A.

Ren Fail. 2014 Jul;36(6):916-24. doi: 10.3109/0886022X.2014.900404. Epub 2014 Mar 31.

PMID:
24678970
11.

Propyl gallate plays a nephroprotective role in early stage of diabetic nephropathy associated with suppression of glomerular endothelial cell proliferation and angiogenesis.

Tian S, Tang J, Liu H, Wang L, Shen J, Li J, Gan Y.

Exp Diabetes Res. 2012;2012:209567. doi: 10.1155/2012/209567. Epub 2012 Sep 4.

12.
13.

Do adenosine receptors offer new therapeutic options for diabetic nephropathy?

San Martín R, Valladares D, Roa H, Troncoso E, Sobrevia L.

Curr Vasc Pharmacol. 2009 Oct;7(4):450-9. Review.

PMID:
19485887
14.

Elevated vascular endothelial growth factor in type 1 diabetic patients with diabetic nephropathy.

Hovind P, Tarnow L, Oestergaard PB, Parving HH.

Kidney Int Suppl. 2000 Apr;75:S56-61.

PMID:
10828763
15.

Antibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes.

de Vriese AS, Tilton RG, Elger M, Stephan CC, Kriz W, Lameire NH.

J Am Soc Nephrol. 2001 May;12(5):993-1000.

16.

[The role of vascular endothelial growth factor in angiogenesis and diabetic retinopathy].

Valiatti FB, Crispim D, Benfica C, Valiatti BB, Kramer CK, Canani LH.

Arq Bras Endocrinol Metabol. 2011 Mar;55(2):106-13. doi: 10.1590/S0004-27302011000200002. Review. Portuguese.

17.

Vascular endothelial growth factor (VEGF) - part 2: in endocrinology and oncology.

Kajdaniuk D, Marek B, Foltyn W, Kos-Kudła B.

Endokrynol Pol. 2011;62(5):456-64. Review.

18.

Renal endothelial dysfunction in diabetic nephropathy.

Cheng H, Harris RC.

Cardiovasc Hematol Disord Drug Targets. 2014;14(1):22-33. Review.

19.

Vascular endothelial growth factor (VEGF) and VEGF receptors in diabetic nephropathy: expression studies in biopsies of type 2 diabetic patients.

Bortoloso E, Del Prete D, Gambaro G, Dalla Vestra M, Sailer A, Baggio B, Antonucci F, Fioretto P, Anglani F.

Ren Fail. 2001 May-Jul;23(3-4):483-93.

PMID:
11499563
20.
Items per page

Supplemental Content

Write to the Help Desk